How MedTech Companies are Responding to the Coronavirus

05/03/2020 iData Research

The most recent reports show the coronavirus, COVID-19, has spread to 83 countries and infected 96,000 people. The total number of fatalities linked to the virus is reported to be over 3,300*. Since t... Read More

Trial Finds Heightened Blood Clot Risk with High Xeljanz Doses, FDA Alerts

05/04/2019 iData Research

Register to receive a free Global Immunology Drugs Market Report Suite report synopsis and brochure The United States Food and Drug Administration (FDA) has recently issued an alert regarding Xeljan... Read More

Humira, Enbrel, Remicade Immunology Drugs Face Stiff Competition in the US from New Biosimilars Due to Patent Expiry

03/11/2017 iData Research

Overall, the U.S. immunology drug market is projected to exceed an estimated $38 billion by 2023 due to the entry of new biosimilars and JAK inhibitors into the market.... Read More

AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments

17/10/2017 iData Research

The U.S. immunology drug market is expected to grow to $68 billion by 2023 due to the entry of new biosimilars and JAK inhibitors.... Read More

Sandoz Erelzi™ (etanercept) Receives Positive Reimbursement Recommendation from Common Drug Review for Treatment of Multiple Inflammatory Diseases

21/08/2017 iData Research

Sandoz, a Novartis division, recently announced that The Canadian Drug Expert Committee (CDEC) as part of the Common Drug Review (CDR) process has issued a positive drug reimbursement recommendation f... Read More